Peter Tebben, MD

2024

• Rickets: The Skeletal Disorders of Impaired Calcium or Phosphate Availability

  Leopold K, Tebben P. Rickets: The Skeletal Disorders of Impaired Calcium or Phosphate Availability. Chapter 21. Pediatric Endocrinology. 4th Edition. Springer Nature Switzerland AG 2024.

  Chapters

• 9295 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study

  Ing S, Harmatz P, Mora S, Imel E, Tebben P, Warren M, Ma N, Khan A, Palermo A, Decallonne B, Lemoine S, Mantovani G, Linglart A, Wasserman H, Barbosa A, Cardot-Bauters C, Roberts M, Mathew A, Adler S, Zillikens M, Clifton-Bligh R, Rejnmark L. 9295 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study. Journal Of The Endocrine Society 2024, 8: bvae163.383. PMCID: PMC11454366, DOI: 10.1210/jendso/bvae163.383.

  Peer-Reviewed Original Research

  Concepts

• 8669 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study

  Ing S, Harmatz P, Mora S, Imel E, Tebben P, Warren M, Ma N, Khan A, Palermo A, Decallonne B, Lemoine S, Mantovani G, Linglart A, Wasserman H, Barbosa A, Cardot-Bauters C, Roberts M, Mathew A, Adler S, Zillikens M, Clifton-Bligh R, Rejnmark L. 8669 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study. Journal Of The Endocrine Society 2024, 8: bvae163.384. PMCID: PMC11454712, DOI: 10.1210/jendso/bvae163.384.

  Peer-Reviewed Original Research

• Erratum to “An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).” Kidney International 2023;105:1058–1076

  Zhu Z, Bo-Ran Ho B, Chen A, Amrhein J, Apetrei A, Carpenter T, Lazaretti-Castro M, Colazo J, McCrystal Dahir K, Geßner M, Gurevich E, Heier C, Simmons J, Hunley T, Hoppe B, Jacobsen C, Kouri A, Ma N, Majumdar S, Molin A, Nokoff N, Ott S, Peña H, Santos F, Tebben P, Topor L, Deng Y, Bergwitz C. Erratum to “An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).” Kidney International 2023;105:1058–1076. Kidney International 2024, 106: 159. PMID: 38906648, PMCID: PMC11610493, DOI: 10.1016/j.kint.2024.05.005.

  Peer-Reviewed Original Research

  Concepts

• CALIBRATE: A phase 3, randomized, open-label study evaluating the efficacy and safety of encaleret (CLTX-305) compared to standard of care in participants with autosomal dominant hypocalcemia type 1 [NCT05680818]

  Rejnmark L, Mannstadt M, Brandi M, Ozono K, Tebben P, Mathew A, Roberts M, Adler S, Gafni R. CALIBRATE: A phase 3, randomized, open-label study evaluating the efficacy and safety of encaleret (CLTX-305) compared to standard of care in participants with autosomal dominant hypocalcemia type 1 [NCT05680818]. Endocrine Abstracts 2024 DOI: 10.1530/endoabs.99.oc2.6.

  Peer-Reviewed Original Research

  Concepts

• Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

  Pinto e Vairo F, Kemppainen J, Vitek C, Whalen D, Kolbert K, Sikkink K, Kroc S, Kruisselbrink T, Shupe G, Knudson A, Burke E, Loftus E, Bandel L, Prochnow C, Mulvihill L, Thomas B, Gable D, Graddy C, Garzon G, Ekpoh I, Porquera E, Fervenza F, Hogan M, El Ters M, Warrington K, Davis J, Koster M, Orandi A, Basiaga M, Vella A, Kumar S, Creo A, Lteif A, Pittock S, Tebben P, Abate E, Joshi A, Ristagno E, Patnaik M, Schimmenti L, Dhamija R, Sabrowsky S, Wierenga K, Keddis M, Samadder N, Presutti R, Robinson S, Stephens M, Roberts L, Faubion W, Driscoll S, Wong-Kisiel L, Selcen D, Flanagan E, Ramanan V, Jackson L, Mauermann M, Ortega V, Anderson S, Aoudia S, Klee E, McAllister T, Lazaridis K. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). Journal Of Translational Medicine 2024, 22: 400. PMID: 38689323, PMCID: PMC11061992, DOI: 10.1186/s12967-024-05185-9.

  Peer-Reviewed Original Research

  Concepts

• An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk

  Salama M, Tebben P, Al Nofal A. An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk. Journal Of Pediatric Endocrinology And Metabolism 2024, 37: 375-379. PMID: 38414167, DOI: 10.1515/jpem-2023-0494.

  Peer-Reviewed Case Reports and Technical Notes

  MeSH Keywords and Concepts

• Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D

  Mohan S, Sheehan M, Tebben P, Wermers R. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D. JCEM Case Reports 2024, 2: luae022. PMID: 38476635, PMCID: PMC10928506, DOI: 10.1210/jcemcr/luae022.

  Peer-Reviewed Original Research

  Citations

  Altmetric

  Concepts

• An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)

  Zhu Z, Bo-Ran Ho B, Chen A, Amrhein J, Apetrei A, Carpenter T, Lazaretti-Castro M, Colazo J, McCrystal Dahir K, Geßner M, Gurevich E, Heier C, Simmons J, Hunley T, Hoppe B, Jacobsen C, Kouri A, Ma N, Majumdar S, Molin A, Nokoff N, Ott S, Peña H, Santos F, Tebben P, Topor L, Deng Y, Bergwitz C. An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Kidney International 2024, 105: 1058-1076. PMID: 38364990, PMCID: PMC11106756, DOI: 10.1016/j.kint.2024.01.031.

  Peer-Reviewed Original Research

  Citations

  Altmetric

  Concepts

• Vitamin D and the kidney

  Kritmetapak K, Tebben PJ, Kumar R. Vitamin d and the kidney. In: Hewison M; Et al editors., Feldman and Pike's vitamin d: biochemistry, physiology and diagnostics. Fifth Edition. London: Academic Press/Elsevier; 2024. vol. One. p. 301-30

  Chapters